InvestorNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Paves Path Forward in ‘Year of Milestones’
November 18, 2020
GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, has made great strides in 2020, citing it as a year of milestones. Among these accomplishments, GoldHaven changed its name to reflect acquisitions, exploration and developments beyond Canada, as well as opened for trading on […]
Knightscope, Inc. Committed to Offering Peace Through Superior Technology with Autonomous Security Robots
November 18, 2020
Knightscope’s ASRs have completed over one million field hours and are continuing to improve over time based on field experience Knightscope designs, engineers, and builds its ASRs in Silicon Valley, continuing to create American jobs in an economy severely impacted by the pandemic The company is committed to changing the way public safety and protection […]
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Issues Letter to Stockholders
November 17, 2020
180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, on Monday released a letter to stockholders from its CEO Dr. James Woody. The letter addresses the closing of the merger […]
InvestorNewsBreaks – Creatd Inc. (NASDAQ: CRTD) Announces Financial Numbers, Key Milestones for Third Quarter
November 17, 2020
Creatd (NASDAQ: CRTD), the parent company of Vocal, a proprietary technology platform for creators of all types, reported its financial numbers and outlined several business milestones achieved during its three-month and nine-month periods ending Sept. 30, 2020. Highlights of the report include Q3 revenues of $425,000, an increase of more than 32% compared to Q2 revenues […]
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Files IND Application for Berubicin in Treatment of GBM
November 17, 2020
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it has submitted an Investigational New Drug (“IND”) application to the U.S. Food and Drug Administration (“FDA”) for Berubicin in the treatment of Glioblastoma Multiforme (“GBM”). […]
InvestorBrandNetwork (IBN) Announces CryptoCurrencyWire Audio Production Featuring Award-Winning Author John Truman Wolfe
November 17, 2020
LOS ANGELES, Nov. 17, 2020 (GLOBE NEWSWIRE) — via — InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest CryptoCurrencyWire Audio Production as part of its sustained effort to provide specialized content distribution via widespread syndication channels. CryptoCurrencyWire’s latest audio production features John […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation Schedule for Upcoming Investor Conferences
November 16, 2020
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced that management will participate in two upcoming investor conferences. According to the update, Processa will participate in one-on-one meetings at the Craig-Hallum Alpha Select Virtual Conference on Tuesday, […]
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
November 16, 2020
Processa’s pipeline includes several clinical-stage drug candidates HANOVER, MD., Nov. 16, 2020 (GLOBE NEWSWIRE) — via InvestorWire – Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, announced today that management will participate in […]
Predictive Oncology (NASDAQ: POAI) CEO Discusses Subsidiaries’ Proprietary Tech, Innovative Media
November 16, 2020
CEO expects results that will “build the stock and raise the stock price” POAI focused on positioning TumorGenesis kits to manufacturers Helomics has largest database of its kind in the world, brings cutting-edge technology to cancer research During a recent NetworkNewsWire exclusive audio interview, Predictive Oncology (NASDAQ: POAI) CEO Carl Schwartz noted recent company milestones […]
Utah Surplus Lines Insurance Licensing Opens Up New Markets and Opportunities for InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTC: IGSTF)
November 16, 2020
Subsidiary InsuraGuest Insurance Agency, LLC, is now licensed to offer surplus lines of casualty and property insurance in the state of Utah This licensing allows for more markets and additional products to be sold, which generates additional revenue and caters to InsuraGuest’s expansion goals in the insurance marketplace Company now offers its products and services […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Q3 2020 Results, Provides Corporate Update
November 13, 2020
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products intended to provide treatment for and improve the survival and/or quality of life for patients with unmet medical needs or no alternative treatment, on Thursday released its financial results for the third quarter of 2020. In addition, Processa provided a […]
Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update
November 12, 2020
Highlights include closing $19.2 million public offering, uplisting to Nasdaq, and positive progress with multiple candidates currently in Processa’s clinical drug pipeline HANOVER, MD., Nov. 12, 2020 (GLOBE NEWSWIRE) — via InvestorWire — Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (“Processa” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of drug products that are intended to […]
77 Public Companies to present at the Virtual Fall Investor Summit on November 16th-18th
November 12, 2020
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) — via InvestorWire — The Virtual Summer Summit will take place on November 16th-18th, connecting 77 presenting small and microcap companies with distinguished investors from around the globe. A full list of issuers are listed below along with webcasting links to view presentations. Company Ticker Webcast URL Actinium Pharmaceuticals ATNM […]
InvestorNewsBreaks – Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) Announces Long-Awaited Integration, Pending Launch of UKLIPZ
November 12, 2020
Loop Insights (TSX.V: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, has announced the upcoming January 2021 launch of UKLIPZ. According to the update, UKLIPZ is the first-ever platform that enables consumers to create verified reviews […]
Predictive Oncology (NASDAQ: POAI) CEO Joins NNW Podcast to Discuss Company’s Prospects; Provides Update on POAI Subsidiaries
November 11, 2020
Predictive Oncology CEO Carl Schwartz featured on NNW’s podcast to discuss the company’s prospects Schwartz elaborated on company’s various divisions, affirming that POAI had begun to see revenue trends stabilize, cash burn rates decline TumorGenesis received overwhelmingly positive feedback on its initial product launches, with plans to extend its technological prowess to address other oncological […]
InvestorNewsBreaks – Hollywall Entertainment Inc. (HWAL) Plans 5G Fiber Network Expansion, Notes Financial Status
November 11, 2020
Hollywall Entertainment (OTC: HWAL), a multifaceted construction/developer, telecommunications, technology, media, entertainment and broadcasting company, has established Hollywall Development Company (“HWDC”). A wholly owned subsidiary, HWDC will specialize in the design, build and management of 5G fiber networks. HWAL announced plans to expand its services to include internet access, streaming media, live television, HW Signature brand […]
InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) Goes Public on Canada’s Next-Gen Stock Exchange
November 11, 2020
Cybin (NEO: CYBN), a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, today made its debut on the global public markets and is now trading on the NEO Exchange under the symbol “CYBN.” The company, which focuses on psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols, recently closed […]
Hollywall Entertainment Inc. Announces Expansion of 5G Fiber Network Business Enterprises and Provides Financial Update
November 10, 2020
WASHINGTON, Nov. 10, 2020 (GLOBE NEWSWIRE) — via InvestorWire — Hollywall Entertainment, Inc. (OTC: HWAL), a multifaceted construction/developer, telecommunications, technology, media, entertainment and broadcasting company, today announces expansion of 5G Fiber Network Business Enterprises and provides a financial update. Hollywall Entertainment, Inc. (“HWAL”) established Hollywall Development Company (“HWDC”), a wholly owned subsidiary, that specializes in […]
InvestorNewsBreaks – Sustainable Green Team Ltd. (SGTM) Releases Financial Report; Notes More Than $5.9M in Revenue for Q3
November 10, 2020
Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, has released its financial information, reporting another profitable quarter. A highlight of the report indicates that the company’s revenues have totaled $24.5 million for the first nine months of 2020. Numbers for the report include both the three […]
InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast Featuring Bestselling Author John Truman Wolfe
November 10, 2020
LOS ANGELES, Nov. 10, 2020 (GLOBE NEWSWIRE) — via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Stock2Me Podcast features […]
InvestorNewsBreaks – Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) Implements ‘Venue Bubble’ – First-Ever End-to-End COVID-19 Venue Solution in Live Environment
November 9, 2020
Loop Insights (TSX.V: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, announced the implementation its “Venue Bubble.” According to the update, the fully integrated contact tracing to rapid testing solution was implemented in a live venue […]
Predictive Oncology (NASDAQ: POAI) Subsidiary’s HSC Technology Optimization Solution Offers Unparalleled Results, Benefits
November 6, 2020
POAI subsidiary Soluble Biotech’s optimization solution shaves time and cost off of traditional options offered by competition Results garnered from company’s HSC optimization are unparalleled in field Soluble Biotech lands first major contract, signifying major company milestone Offering a proprietary automated High Throughput Self-Interaction Chromatography(TM) (“HSC”) Technology Platform, Predictive Oncology (NASDAQ: POAI) provides biomedical and […]
Knightscope, Inc. Is ‘One to Watch’
November 5, 2020
Knightscope is a leader in the development of autonomous security capabilities and is on target to disrupt the $500 billion security industry The company is presently in the process of raising up to $25 million in additional growth capital as it prepares for a possible public listing With more than 16,000 investors, over $70 million […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Board Appointment of Dr. Khalid Islam
November 5, 2020
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with a high unmet medical need, today announced the appointment of Dr. Khalid Islam to its board of directors. Dr. Islam was the chairman and CEO of Gentium S.p.A. (a Nasdaq-listed company; 2009-2014) where he led […]
InvestorNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) (OTC: IGSTF) Marks Milestone with Ability to Provide True Nationwide Coverage
November 5, 2020
InsuraGuest Technologies (TSX.V: ISGI) (OTC: IGSTF), an innovative insurtech provider, today announced that its wholly owned subsidiary InsuraGuest Insurance Agency LLC (“IG Agency”) has been approved as a resident surplus lines producer. According to the update, IG Agency is now licensed to offer surplus lines casualty and surplus lines property insurance in the state of […]
InvestorNewsBreaks – Sanwire Corporation (SNWR) Reaches Noteworthy Milestone as Growing Number of Artists Join Program
November 5, 2020
Sanwire (OTC: SNWR), a diversified company with a focus on technologies for the entertainment industry, has announced a milestone for Intercept PLUS — more than 50 artists have signed up for the innovative, invitation-only label services program. Available through Intercept Music Inc., a wholly owned Sanwire subsidiary, Intercept PLUS was launched in May 2020. To […]
InsuraGuest Approved as Resident Surplus Lines Producer in Utah; Changes Plan for Debt Conversion
November 5, 2020
VANCOUVER, British Columbia, Nov. 05, 2020 (GLOBE NEWSWIRE) — via InvestorWire – InsuraGuest Technologies, Inc.® (TSX-V: ISGI) (“InsuraGuest” or the “Company”) today announces that its wholly owned subsidiary InsuraGuest Insurance Agency, LLC (“IG Agency”) has been approved as a resident surplus lines producer, licensed to offer surplus lines casualty and surplus lines property insurance in the state of Utah. […]
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Research Report
November 4, 2020
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, was featured in an institutional research report by Craig-Hallum Capital Group LLC. The report discusses Craig-Hallum’s research coverage of PCSA and details the company’s experienced management team and its ownership […]
InvestorNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Achieves Major Milestone in US REE Production
November 3, 2020
Energy Fuels (NYSE American: UUUU) (TSX: EFR) today announced that the company has produced a rare earth element (“REE”) carbonate concentrate (“REE Concentrate”) on a pilot scale at its 100% owned White Mesa Mill (the “Mill”), located near Blanding, Utah. According to the update, the REE Concentrate was produced using the Mill’s existing infrastructure and […]
Processa Pharmaceuticals Schedules Conference Call to Discuss Third Quarter Results and Provide Drug Development Update on Nov. 12 at 5:30 p.m. ET
November 3, 2020
HANOVER, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) — via InvestorWire — Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients who have high unmet medical need conditions, today announces it will host a conference call and live webcast on Nov. […]
CNS Pharmaceuticals (NASDAQ: CNSP) Announces Completion of Drug Manufacturing for Brain Cancer Trial
November 2, 2020
Houston-based CNS Pharmaceuticals is preparing to launch Phase 2 clinical testing of a novel brain cancer-fighting drug candidate called Berubicin early next year The biopharmaceutical company recently announced that a U.S.-based company contracted to make Berubicin has completed its production process and an Italian company working on a dual track in Europe is expected to […]
Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Achieves Debt-Free Milestone, Provides ‘Clean Slate’ for Increased Uranium Production
November 2, 2020
One of few uranium, natural resource companies in North America with no debt Sets stage for increasing uranium production as markets improve; launching rare earth element initiative Allows rare earth production as markets warrant Applauds U.S. government for securing agreement to limit imports of uranium from Russia Energy Fuels (NYSE American: UUUU) (TSX: EFR), the […]
InvestorNewsBreaks – GreenBox POS (GRBX) Files for Nasdaq Capital Market Uplisting
October 30, 2020
GreenBox (OTCQB:GRBX), an emerging financial technology company leveraging proprietary blockchain security to build customized payment solutions, today announced that it has submitted its application to uplist the company’s common stock on the Nasdaq Capital Market (“Nasdaq”). If approved, the company would begin trading under the “GBOX” ticker it has reserved. “We are very pleased the […]
GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Cites 2020 as Year of Milestones
October 30, 2020
Changed name to reflect acquisitions, exploration, developments beyond Canada Created opportunity for American investors to participate through OTCQB Acquired seven advanced gold projects in Maricunga Gold Belt with plans to start drilling in early 2021 GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), previously Altum Resource Corp., is a mineral-exploration and resource-development company focused on identifying economically viable […]
InvestorNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in BioWorld Article
October 30, 2020
VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in a recent BioWorld article titled, “CBC-funded Affamed merges with Everinsight, extends portfolio with Kissei PD candidate.” The publication discusses the merging of Affamed Therapeutics Ltd., an emerging biopharmaceutical company focused on […]
ev Transportation Services Inc. Is ‘One to Watch’
October 29, 2020
evTS provides a versatile, purpose built, all-electric light duty utility vehicle, the Firefly ESV, that can be customized for various service industry applications Its durable modular design, agility and long-lasting battery make it an ideal vehicle for a wide range of tasks and operations in sectors such as parking enforcement, security, building maintenance, last-mile urban […]
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Conditional FDA Acceptance of Proprietary Name for Lead Drug Candidate
October 29, 2020
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has received conditional FDA acceptance of the proprietary name REQORSA(TM), its lead drug candidate for treatment of non-small cell lung cancer. The drug candidate was known previously by the laboratory designation GPX-001. The approval of the new […]
Friendable Inc. (FDBL) Fan Pass Live Platform Bridges Gap Between Artist Performances, Fan Experience
October 29, 2020
Fan Pass has completed beta testing for iOS and Android, apps now live in both Apple App Stores and Google Play U.S. video-streaming industry expected to reach $842 billion by 2027 Friendable has partnered with Brightcove for Fan Pass Live Streaming and future OTT platform expansion to include Roku, iOS, Android, Apple TV, Android TV […]
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Completion of Drug for Clinical Trials
October 29, 2020
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, has through its European manufacturer, BSP Pharmaceuticals S.p.A. (“BSP”), finished manufacturing its lead drug candidate for upcoming Phase 2 clinical trials. Berubicin is CNSP’s lead drug candidate for the treatment of […]
InvestorNewsBreaks – Predictive Oncology (NASDAQ: POAI) CEO Provides Company Updates on Exclusive NNW Audio Interview
October 27, 2020
Predictive Oncology (NASDAQ: POAI) CEO Carl Schwartz was featured in a recent NetworkNewsWire (“NNW”) audio interview. During the interview, Schwartz provided updates on the company’s subsidiaries, noted recent company milestones and outlined near-term goals. POAI, a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has four wholly owned subsidiaries: […]